Apollo Hospitals Enterprise Limited Share Price & Analysis
₹8,314.5Updated 5 Jun 2026, 03:30 pm IST
LTP
₹8,314.5
—
Open
₹8,265
High
₹8,341
Low
₹8,240
Close
₹8,249
52W High
₹8,490
52W Low
₹6,680
Volume
188K
Lot Size
125
Sector
Healthcare
Market Cap
₹1.2L Cr
Face Value
₹5
Large CapNIFTY 100NIFTY 200NIFTY 50NIFTY 500
Price Chart
Fundamentals
P/E
59.5
Sector P/E
48.9
P/B
12.62
EPS
₹125.32
ROE
22.1%
ROCE
17.9%
D/E Ratio
0.9
Div Yield
0.23%
Book Value
₹659
+
Strengths
- ✓Excellent return on equity (ROE 22.1%)
- ✓Efficient capital deployment (ROCE 17.9%)
−
Concerns
- ✗High premium to book value (P/B 12.6x)
- ✗Trading near 52-week high (₹8,490)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
| LUPIN Lupin Limited | ₹2,260 | ₹1.0L Cr | 17.9 | 4.6 | 29.1 | 30.3 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
APOLLOHOSP · as of Mar 2026
Promoters29.34%▲0.01
FII42.74%▼2.53
DII22.29%▲2.32
Public5.41%▲0.20
Govt0.23%
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 29.33% | 29.33% | 29.33% | 29.33% | 29.33% | 29.34% |
| FII | 46.25% | 45.63% | 43.92% | 45.37% | 45.27% | 42.74% |
| DII | 18.87% | 19.55% | 21.13% | 19.94% | 19.97% | 22.29% |
| Public | 5.32% | 5.26% | 5.38% | 5.12% | 5.21% | 5.41% |
| Govt | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% |
Corporate Events
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
Dividend19 May 2026
Interim Dividend - Rs 10 Per Sh
Dividend15 Feb 2026
Dividend - Rs 10 Per Share
Dividend18 Aug 2025
Interim Dividend - Rs 9 Per Share
Record: 14 Feb 2025
Dividend13 Feb 2025
Annual General Meeting/Dividend - Rs 10 Per Share
Record: 16 Aug 2024
Dividend15 Aug 2024
Interim Dividend - Rs 6 Per Share
Dividend19 Feb 2024
Annual General Meeting/Dividend - Rs 9 Per Share
Record: 18 Aug 2023
Dividend17 Aug 2023
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹6.5K Cr ▲2.7% | ₹6.3K Cr ▲7.9% | ₹5.8K Cr ▲4.5% | ₹5.6K Cr ▲1.2% | ₹5.5K Cr ▼1.1% | ₹5.6K Cr ▲9.9% | ₹5.1K Cr ▲2.9% | ₹4.9K Cr |
| Op. Profit | ₹965 Cr ▲2.6% | ₹941 Cr ▲10.4% | ₹852 Cr ▲10.6% | ₹770 Cr ▲1.0% | ₹762 Cr ▼6.6% | ₹816 Cr ▲20.9% | ₹675 Cr ▲5.5% | ₹640 Cr |
| OPM | 15.0% ▲0.0% | 15.0% ▲0.0% | 15.0% ▲7.1% | 14.0% ▲0.0% | 14.0% ▼6.7% | 15.0% ▲15.4% | 13.0% ▲0.0% | 13.0% |
| Net Profit | ₹516 Cr ▲4.5% | ₹494 Cr ▲12.0% | ₹441 Cr ▲6.5% | ₹414 Cr ▲9.2% | ₹379 Cr ▼4.3% | ₹396 Cr ▲25.3% | ₹316 Cr ▲22.5% | ₹258 Cr |
| EPS (₹) | 34.93 ▲5.2% | 33.19 ▲10.3% | 30.1 ▲11.1% | 27.1 ▲4.7% | 25.89 ▼1.7% | 26.34 ▲24.1% | 21.23 ▲20.3% | 17.65 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹25.2K Cr ▲15.8% | ₹21.8K Cr ▲14.4% | ₹19.1K Cr ▲14.7% | ₹16.6K Cr ▲13.3% | ₹14.7K Cr ▲38.9% | ₹10.6K Cr ▼6.1% | ₹11.2K Cr ▲16.9% | ₹9.6K Cr ▲16.7% | ₹8.2K Cr ▲13.6% | ₹7.3K Cr |
| Expenses | ₹21.5K Cr ▲14.4% | ₹18.8K Cr ▲12.6% | ₹16.7K Cr ▲14.6% | ₹14.5K Cr ▲16.6% | ₹12.5K Cr ▲32.4% | ₹9.4K Cr ▼2.4% | ₹9.7K Cr ▲13.0% | ₹8.5K Cr ▲14.9% | ₹7.4K Cr ▲14.1% | ₹6.5K Cr |
| Op. Profit | ₹3.8K Cr ▲24.3% | ₹3.0K Cr ▲26.7% | ₹2.4K Cr ▲15.9% | ₹2.1K Cr ▼5.7% | ₹2.2K Cr ▲92.0% | ₹1.1K Cr ▼28.3% | ₹1.6K Cr ▲48.7% | ₹1.1K Cr ▲33.6% | ₹801 Cr ▲9.1% | ₹734 Cr |
| OPM | 15.0% ▲7.1% | 14.0% ▲7.7% | 13.0% ▲8.3% | 12.0% ▼20.0% | 15.0% ▲36.4% | 11.0% ▼21.4% | 14.0% ▲27.3% | 11.0% ▲10.0% | 10.0% ▲0.0% | 10.0% |
| Other Income | ₹217 Cr ▼2.3% | ₹222 Cr ▲80.5% | ₹123 Cr ▲64.0% | ₹75 Cr ▼79.6% | ₹368 Cr ▲257.3% | ₹103 Cr ▼53.6% | ₹222 Cr ▲753.8% | ₹26 Cr ▲8.3% | ₹24 Cr ▼60.0% | ₹60 Cr |
| Interest | ₹450 Cr ▼1.7% | ₹458 Cr ▲2.0% | ₹449 Cr ▲17.8% | ₹381 Cr ▲0.5% | ₹379 Cr ▼15.6% | ₹449 Cr ▼15.8% | ₹533 Cr ▲63.0% | ₹327 Cr ▲10.8% | ₹295 Cr ▲14.8% | ₹257 Cr |
| Depreciation | ₹876 Cr ▲15.6% | ₹758 Cr ▲10.3% | ₹687 Cr ▲11.7% | ₹615 Cr ▲2.3% | ₹601 Cr ▲4.9% | ₹573 Cr ▼7.6% | ₹620 Cr ▲56.6% | ₹396 Cr ▲10.3% | ₹359 Cr ▲14.3% | ₹314 Cr |
| PBT | ₹2.7K Cr ▲30.5% | ₹2.0K Cr ▲47.8% | ₹1.4K Cr ▲20.6% | ₹1.1K Cr ▼27.5% | ₹1.6K Cr ▲614.0% | ₹221 Cr ▼66.5% | ₹660 Cr ▲76.9% | ₹373 Cr ▲118.1% | ₹171 Cr ▼23.0% | ₹222 Cr |
| Tax % | 25.0% ▼3.8% | 26.0% ▼18.8% | 32.0% ▲45.5% | 22.0% ▼26.7% | 30.0% ▼21.1% | 38.0% ▲11.8% | 34.0% ▼27.7% | 47.0% ▼27.7% | 65.0% ▲58.5% | 41.0% |
| Net Profit | ₹2.0K Cr ▲33.1% | ₹1.5K Cr ▲61.0% | ₹935 Cr ▲10.8% | ₹844 Cr ▼23.8% | ₹1.1K Cr ▲708.8% | ₹137 Cr ▼68.3% | ₹432 Cr ▲116.0% | ₹200 Cr ▲233.3% | ₹60 Cr ▼54.2% | ₹131 Cr |
| EPS (₹) | 135.04 ▲34.3% | 100.56 ▲60.9% | 62.5 ▲9.7% | 56.97 ▼22.4% | 73.42 ▲601.9% | 10.46 ▼68.0% | 32.7 ▲92.8% | 16.96 ▲100.9% | 8.44 ▼46.9% | 15.88 |
| Div Payout | 15.0% ▲15.4% | 13.0% ▼50.0% | 26.0% ▲0.0% | 26.0% ▲62.5% | 16.0% ▼44.8% | 29.0% ▲61.1% | 18.0% ▼48.6% | 35.0% ▼40.7% | 59.0% ▲55.3% | 38.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹72 Cr ▲0.0% | ₹72 Cr ▲0.0% | ₹72 Cr ▲0.0% | ₹72 Cr ▲0.0% | ₹72 Cr ▲0.0% | ₹72 Cr ▲2.9% | ₹70 Cr ▲0.0% | ₹70 Cr ▲0.0% | ₹70 Cr ▲0.0% | ₹70 Cr |
| Reserves | ₹9.0K Cr ▲10.8% | ₹8.1K Cr ▲18.6% | ₹6.9K Cr ▲12.0% | ₹6.1K Cr ▲10.4% | ₹5.6K Cr ▲22.5% | ₹4.5K Cr ▲38.6% | ₹3.3K Cr ▲0.2% | ₹3.3K Cr ▲2.6% | ₹3.2K Cr ▼1.9% | ₹3.2K Cr |
| Borrowings | ₹8.0K Cr ▲1.6% | ₹7.9K Cr ▲47.5% | ₹5.3K Cr ▲23.1% | ₹4.3K Cr ▲6.5% | ₹4.1K Cr ▼2.2% | ₹4.2K Cr ▲15.7% | ₹3.6K Cr ▼2.1% | ₹3.7K Cr ▲7.2% | ₹3.4K Cr ▲9.7% | ₹3.1K Cr |
| Other Liabilities | ₹4.9K Cr ▲6.6% | ₹4.6K Cr ▲2.1% | ₹4.5K Cr ▲15.1% | ₹3.9K Cr ▲8.9% | ₹3.6K Cr ▲35.8% | ₹2.6K Cr ▼39.6% | ₹4.4K Cr ▲101.7% | ₹2.2K Cr ▲12.6% | ₹1.9K Cr ▲15.1% | ₹1.7K Cr |
| Total Liabilities | ₹21.9K Cr ▲6.3% | ₹20.6K Cr ▲23.3% | ₹16.7K Cr ▲16.1% | ₹14.4K Cr ▲8.7% | ₹13.3K Cr ▲16.4% | ₹11.4K Cr ▲0.9% | ₹11.3K Cr ▲23.2% | ₹9.2K Cr ▲6.6% | ₹8.6K Cr ▲6.1% | ₹8.1K Cr |
| Assets | ||||||||||
| Fixed Assets | ₹11.3K Cr ▲2.5% | ₹11.0K Cr ▲13.7% | ₹9.7K Cr ▲13.4% | ₹8.5K Cr ▲2.7% | ₹8.3K Cr ▲22.4% | ₹6.8K Cr ▼8.8% | ₹7.4K Cr ▲49.2% | ₹5.0K Cr ▲4.4% | ₹4.8K Cr ▲4.0% | ₹4.6K Cr |
| CWIP | ₹1.0K Cr ▲11.4% | ₹921 Cr ▲5.5% | ₹873 Cr ▲43.1% | ₹610 Cr ▲1226.1% | ₹46 Cr ▼80.3% | ₹234 Cr ▼0.8% | ₹236 Cr ▼71.3% | ₹822 Cr ▲15.4% | ₹712 Cr ▲105.2% | ₹347 Cr |
| Investments | ₹3.0K Cr ▲20.9% | ₹2.5K Cr ▲152.2% | ₹986 Cr ▲71.8% | ₹574 Cr ▼29.7% | ₹816 Cr ▼39.2% | ₹1.3K Cr ▲209.4% | ₹434 Cr ▼6.1% | ₹462 Cr ▲31.3% | ₹352 Cr ▼13.3% | ₹406 Cr |
| Other Assets | ₹6.7K Cr ▲6.5% | ₹6.2K Cr ▲19.7% | ₹5.2K Cr ▲10.8% | ₹4.7K Cr ▲14.8% | ₹4.1K Cr ▲35.1% | ₹3.0K Cr ▼4.7% | ₹3.2K Cr ▲9.9% | ₹2.9K Cr ▲5.1% | ₹2.8K Cr ▲0.0% | ₹2.8K Cr |
| Total Assets | ₹21.9K Cr ▲6.3% | ₹20.6K Cr ▲23.3% | ₹16.7K Cr ▲16.1% | ₹14.4K Cr ▲8.7% | ₹13.3K Cr ▲16.4% | ₹11.4K Cr ▲0.9% | ₹11.3K Cr ▲23.2% | ₹9.2K Cr ▲6.6% | ₹8.6K Cr ▲6.1% | ₹8.1K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹2.1K Cr ▲11.3% | ₹1.9K Cr ▲39.4% | ₹1.4K Cr ▼18.8% | ₹1.7K Cr ▲34.1% | ₹1.3K Cr ▼2.2% | ₹1.3K Cr ▲42.9% | ₹905 Cr ▲68.5% | ₹537 Cr ▼13.8% | ₹623 Cr ▲4.4% | ₹597 Cr |
| Investing CF | ₹-3.4K Cr ▼120.0% | ₹-1.5K Cr ▼79.3% | ₹-857 Cr ▼14.7% | ₹-747 Cr ▲15.1% | ₹-880 Cr ▼204.5% | ₹-289 Cr ▲59.4% | ₹-711 Cr ▼75.6% | ₹-405 Cr ▲64.8% | ₹-1.2K Cr ▼29.7% | ₹-888 Cr |
| Financing CF | ₹1.3K Cr ▲523.5% | ₹-311 Cr ▲50.9% | ₹-633 Cr ▲20.1% | ₹-792 Cr ▼132.9% | ₹-340 Cr ▲62.6% | ₹-910 Cr ▼323.3% | ₹-215 Cr ▼99.1% | ₹-108 Cr ▼122.6% | ₹477 Cr ▲44.5% | ₹330 Cr |
| Net Cash Flow | ₹73 Cr ▲1.4% | ₹72 Cr ▲163.7% | ₹-113 Cr ▼171.5% | ₹158 Cr ▲259.1% | ₹44 Cr ▼53.2% | ₹94 Cr ▲570.0% | ₹-20 Cr ▼183.3% | ₹24 Cr ▲146.2% | ₹-52 Cr ▼233.3% | ₹39 Cr |
| Free Cash Flow | ₹439 Cr ▼44.1% | ₹785 Cr ▲211.5% | ₹252 Cr ▼75.9% | ₹1.0K Cr ▲6.1% | ₹984 Cr ▲25.8% | ₹782 Cr ▲235.6% | ₹233 Cr ▲377.4% | ₹-84 Cr ▼82.6% | ₹-46 Cr ▲88.3% | ₹-393 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 51d ▲6.3% | 48d ▼2.0% | 49d ▲11.4% | 44d ▼4.3% | 46d ▲39.4% | 33d ▼15.4% | 39d ▲5.4% | 37d ▼2.6% | 38d ▲5.6% | 36d |
| Inventory Days | 16d ▼5.9% | 17d ▲0.0% | 17d ▼19.0% | 21d ▲31.3% | 16d ▼67.3% | 49d ▲6.5% | 46d ▼9.8% | 51d ▲8.5% | 47d ▼4.1% | 49d |
| Days Payable | 72d ▼18.2% | 88d ▲7.3% | 82d ▲3.8% | 79d ▲6.8% | 74d ▲23.3% | 60d ▲7.1% | 56d ▲1.8% | 55d ▲7.8% | 51d ▼22.7% | 66d |
| Cash Conv. Cycle | -6d ▲73.9% | -23d ▼43.8% | -16d ▼14.3% | -14d ▼16.7% | -12d ▼154.5% | 22d ▼24.1% | 29d ▼12.1% | 33d ▼2.9% | 34d ▲78.9% | 19d |
| Working Capital Days | -6d ▲68.4% | -19d ▼1800.0% | -1d ▼120.0% | 5d ▲225.0% | -4d ▲50.0% | -8d ▼166.7% | -3d ▼137.5% | 8d ▼70.4% | 27d ▲68.8% | 16d |
| ROCE | 17.0% ▲13.3% | 15.0% ▲7.1% | 14.0% ▼17.6% | 17.0% ▲112.5% | 8.0% ▼42.9% | 14.0% ▲40.0% | 10.0% ▲42.9% | 7.0% ▼12.5% | 8.0% ▼11.1% | 9.0% |
Source: Screener.in · Lower days = better efficiency
Deep Dive Analysis
About Apollo Hospitals Enterprise Limited
Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.
Healthcare · Healthcare Services
Related Analysis
Frequently Asked Questions
What is Apollo Hospitals Enterprise Limited share price today?▾
Apollo Hospitals Enterprise Limited (APOLLOHOSP) is currently trading at ₹8,314.5 on NSE, as of the last market session. Prices update daily after market close on MarketNetra.
Is Apollo Hospitals Enterprise Limited available in F&O (Futures & Options)?▾
Yes, Apollo Hospitals Enterprise Limited (APOLLOHOSP) is part of the NSE F&O segment with a lot size of 125 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Apollo Hospitals Enterprise Limited 52-week high and low?▾
Apollo Hospitals Enterprise Limited's 52-week high is ₹8,490 and the 52-week low is ₹6,680. The current price of ₹8,314.5 is 2.1% below the 52W high.
What is Apollo Hospitals Enterprise Limited P/E ratio?▾
Apollo Hospitals Enterprise Limited's current P/E ratio is 59.5. This indicates the market is paying ₹59.5 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Apollo Hospitals Enterprise Limited options?▾
Apollo Hospitals Enterprise Limited options are traded on NSE with monthly expiry contracts (lot size: 125 shares). To trade APOLLOHOSP options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.